Candel Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CADL | CANTA.ST | SNDX | CTMX | AURA | ANL | |
|---|---|---|---|---|---|---|
| Market cap | 692.49M | 475.36M | 940.80M | 512.06M | 689.64M | 618.86M |
| P/E (TTM) | — | 2.5 | — | — | — | — |
| Forward P/E | -14.5 | -1.8 | -14.4 | -5.0 | -3.3 | -32.7 |
| Price/book | 5.5 | 1.6 | -54.7 | 1.7 | 2.2 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +73.28% | −48.13% | −5.36% | −48.22% | +14.71% | +560.69% |
| Today | +2.61% | −2.09% | −26.87% | +7.80% | +6.57% | +0.31% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CADL news ›Cannabichromene (CBC)-Derived Compounds Trigger Cell Death in Prostate Cancer Cells, Study Finds
Senior Trump Adviser Says President Is “Entirely Confident” DEA Will Quickly Finalize Marijuana Rescheduling Study Finds No Significant Overall Increase in Impairment Among Frequent Marijuana Users Following Legalization Scientists have…
Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026
AI-enabled digital pathology analysis shows aglatimagene significantly increased lymphocyte infiltration and immune engagement with tumor cells compared to standard-of-care radiotherapy alone two ... Candel Therapeutics Announces New Data…
Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate...
With follow-up through March 15, 2026 (median, 58.0 months), the phase 3 trial showed that patients with intermediate-risk disease (635 patients) treated with aglatimagene plus EBRT experienced a 41% reduction in the risk of prostate…
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmace... NEEDHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the…
Recent Analysts’ Ratings Changes for Candel Therapeutics (CADL)
Several brokerages have updated their recommendations and price targets on shares of Candel Therapeutics (NASDAQ: CADL) in the last few weeks: 10/22/2026 – Candel Therapeutics is now covered by Jefferies Financial Group. They set a “buy”…
Candel Therapeutics, Inc. Announces Appointment of Martine Zimmermann to Board of Directors, Effective September 8, 2026
Candel Therapeutics, Inc. announced the appointment of Martine Zimmermann, PharmD, to the Company?s Board of Directors effective September 8, 2026.Dr. Zimmermann has served as the Executive Vice... announced the appointment of Martine…
Candel Therapeutics Q2 Loss Widens
Candel Therapeutics reported a Q2 net loss Thursday of $0.52 per diluted share, widening from a loss of $0.09 a year earlier. Analysts surveyed by FactSet expected a loss of $0.23. As expected, no... Biotechnology & Medical Research Candel…
Candel Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Candel Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time CADL price, Nasdaq stock exchange Relative Strength Chart Candel Therapeutics, Inc. Biotechnology & Medical Research All financial…
Candel Therapeutics to Present at November Investor Conferences
NEEDHAM, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmace... Candel Therapeutics to Present at November Investor Conferences NEEDHAM, Mass., Oct. 27,…
Candel Therapeutics Appoints Maria Ostrovsky as General Counsel
Seasoned legal and compliance executive brings global product launch, strategic transaction and international operational experience as Candel pre... Candel Therapeutics Appoints Maria Ostrovsky as General Counsel - Seasoned legal and…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com9
- marketscreener.com7
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.